Innprot offers products and technologies for multiplexing cell-based assays in drug discovery and development, primary cells, immortalized cell lines, and recombinant cell lines. Distinguished by a proprietary technology for G protein-coupled receptor (GPCR) screening, Innoprot excels in identifying compounds of the utmost efficacy while mitigating undesired side effects. Innprot also offers custom services which includes comprehensive screening services with a specialized focus on GPCRs, Fibrosis, and Neurodegenerative diseases such as Alzheimer’s Disease, Parkinson’s Disease, and ALS.